Swiss National Bank’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-60,300
| Closed | -$472K | – | 2452 |
|
|
2024
Q4 | $472K | Hold |
60,300
| – | – | ﹤0.01% | 2409 |
|
|
2024
Q3 | $793K | Hold |
60,300
| – | – | ﹤0.01% | 2313 |
|
|
2024
Q2 | $728K | Buy |
+60,300
| New | +$728K | ﹤0.01% | 2302 |
|
|
2023
Q1 | – | Sell |
-77,100
| Closed | -$376K | – | 2673 |
|
|
2022
Q4 | $376K | Hold |
77,100
| – | – | ﹤0.01% | 2622 |
|
|
2022
Q3 | $1.11M | Hold |
77,100
| – | – | ﹤0.01% | 2277 |
|
|
2022
Q2 | $1.17M | Buy |
77,100
+15,100
| +24% | +$229K | ﹤0.01% | 2274 |
|
|
2022
Q1 | $737K | Buy |
62,000
+4,700
| +8% | +$55.9K | ﹤0.01% | 2509 |
|
|
2021
Q4 | $929K | Hold |
57,300
| – | – | ﹤0.01% | 2507 |
|
|
2021
Q3 | $1.64M | Hold |
57,300
| – | – | ﹤0.01% | 2177 |
|
|
2021
Q2 | $1.94M | Buy |
57,300
+11,000
| +24% | +$372K | ﹤0.01% | 2122 |
|
|
2021
Q1 | $1.4M | Buy |
46,300
+1,200
| +3% | +$36.3K | ﹤0.01% | 2207 |
|
|
2020
Q4 | $2.23M | Hold |
45,100
| – | – | ﹤0.01% | 1835 |
|
|
2020
Q3 | $1.73M | Buy |
45,100
+700
| +2% | +$26.9K | ﹤0.01% | 1793 |
|
|
2020
Q2 | $1.92M | Buy |
44,400
+5,900
| +15% | +$255K | ﹤0.01% | 1738 |
|
|
2020
Q1 | $1.01M | Buy |
38,500
+1,100
| +3% | +$28.7K | ﹤0.01% | 1823 |
|
|
2019
Q4 | $1.17M | Buy |
37,400
+24,700
| +194% | +$772K | ﹤0.01% | 2054 |
|
|
2019
Q3 | $331K | Hold |
12,700
| – | – | ﹤0.01% | 2444 |
|
|
2019
Q2 | $290K | Buy |
+12,700
| New | +$290K | ﹤0.01% | 2519 |
|